Moderna
Moderna to Build its First African Vaccine Plant in Kenya Worth $500M
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit “Cookie Settings” to provide a controlled consent.
Moderna starts human trials of an mRNA-based flu shot
Moderna gave its mRNA-based seasonal flu vaccine to the first set of volunteers in a clinical trial, the pharmaceutical company announced today. The start of the trial marks the next stage of the company’s work on this type of vaccine technology after the overwhelming success of its COVID-19 vaccine, which was built using the same strategy. Before the COVID-19 pandemic, mRNA vaccines were still largely experimental, even as they were heralded as the future of vaccine development. People who get an mRNA vaccine are injected with tiny snippets of genetic material from the target virus. Their cells use that genetic information to build bits of the virus, which the body’s immune system learns to fight against. The high efficacy of the mRNA COVID-19 vaccines made by Moderna and Pfizer / BioNTec...
Israel, Bahrain leaders discuss Iran, possible vaccine plant
Israeli Prime Minister Benjamin Netanyahu and Bahrain’s Crown Prince Sheikh Salman bin Hamad Al Khalifa on Thursday discussed Iran and the possible involvement of the Gulf state in establishing a vaccine plant in Israel, the two countries said. Bahrain and the United Arab Emirates formalised ties with Israel on Sept. 15 in part over shared concerns about Iran, in a deal forged by former U.S. President Donald Trump. Trump withdrew from a 2015 nuclear deal between Tehran and world powers, a move praised by Israel which has objected to the accord. His successor, President Joe Biden, wants to rejoin the deal. But in the week since Washington offered to talk with Tehran about reviving the nuclear deal, Iran has curbed U.N. monitoring and threatened to boost its uranium enrichment. Tehran denies...
Coronavirus: Concern grows over potential superspreader event during US Capitol riot
Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators. Rep. Bonnie Watson Coleman, D-N.J., tested positive on Monday while experiencing mild symptoms, and said in a statement that she believes she caught the virus from her fellow lawmakers while hunkering down as Capitol Police struggled for hours to contain a Trump-inspired mob attack on the Capitol. Lawmakers were trapped in a room near the Capitol with hundreds of others, in some cases for hours, where at least one person who later tested positive for the coronavirus was present. The Office of the Attending P...
Joe Biden receives second dose of coronavirus vaccine on camera
Joe Biden on Monday received the second dose of the Pfizer/BioNTech Covid-19 vaccine on camera, as part of an effort by the President-elect’s incoming administration to reassure the country of the safety of the vaccines. Biden was administered the shot in his left arm by Ric Cuming, chief nurse executive at ChristianaCare’s Christiana Hospital in Newark, Delaware, according to Biden’s transition team. The President-elect said he would be announcing his plan to “get the entire Covid operation up and running,” including the necessary costs, on Thursday. Biden said he had a meeting with members of his team later Monday afternoon. Biden said he was “not afraid of taking the oath outside,” and that his team has been getting briefed, when asked if he had any fears about taking the oath of office...
Official: One million Americans vaccinated against coronavirus
More than a million people have received their first dose of a Covid-19 vaccine in the United States, Centers for Disease Control and Prevention (CDC) director Robert Redfield said Wednesday. “The United States achieved an early but important milestone today — jurisdictions have now reported that more than one million people have received their first dose of Covid-19 vaccine since administration began 10 days ago,” said Redfield. In a call with reporters, Moncef Slaoui, chief advisor of the government’s Operation Warp Speed, said that the objective of immunizing 20 million people this month was “unlikely to be met.” But he said the US was still aiming for 100 million people immunized by the end of the first quarter of 2021, and another 100 million by the second quarter. Three million doses...
Reports: New coronavirus strain from Britain identified in Nigeria
A new strain of the novel coronavirus disease (COVID-19) that grounded the global economy for all of 2020, has been identified in Nigeria. The mutant variant was first identified in the United Kingdom (UK) and has caused several countries to ban flights from the UK. It has also led the UK government to announce a slew of fresh restrictions and lockdowns. Newsmen report that this new strain has been identified in Nigeria by scientists at the Africa Centre of Excellence for Genomics of Infectious Diseases (ACEGID), at the Redeemers University in Ede, Osun State. In a publication in Virological, a website for the global Genomics community, the scientists say they found the same variant “lineage B.1.1.7” in Osun State, Southwest Nigeria since August 3, 2020, when the first sample was collected...
Moderna, McKesson, U.S. Army general begin rolling out new coronavirus vaccine
Distribution of Moderna Inc’s COVID-19 vaccine to more than 3,700 locations in the United States has begun, vastly widening the rollout started last week by Pfizer Inc, U.S Army General Gustave Perna said on Saturday. Moderna has already moved vaccines from its manufacturing plants to warehouses operated by distributor McKesson Corp where they are being packed into containers and loaded on to trucks on Saturday, Perna said during a news conference. Trucks will set out on Sunday and shipments will start reaching healthcare providers as soon as Monday, he said. The Food and Drug Administration on Friday approved an emergency use authorization for Moderna’s vaccine, the second COVID-19 vaccine to be approved. The jab developed by Pfizer and its German partner BioNTech SE was approved Dec. 11....
First Americans vaccinated as U.S. death toll passes 300,000
An intensive care unit nurse became the first person in the United States to receive the Pfizer/BioNTech COVID-19 vaccine on Monday, calling it a sign that “healing is coming,” as the U.S. coronavirus death toll crossed a staggering 300,000 lives lost. Sandra Lindsay, who has treated some of the sickest COVID-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s COVID-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo. “It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history. “I want to instil...
Interpol raises the alarm over fake coronavirus vaccines
The International Criminal Police Organisation (INTERPOL) has alerted Nigeria, South Africa, the United Kingdom, the United States, and 190 other countries of threat from organised criminal groups during the upcoming COVID-19 vaccination campaigns, including fake vaccines and the theft of supplies. The alert came as the UK yesterday became the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine for widespread use. The need for a vaccine has become more urgent globally and nationally with Nigeria recording over 67,000 COVID-19 infections and over 1,000 associated fatalities, according to the Nigeria Centre for Disease Control. The World Health Organisation (WHO) has so far identified 49 “candidate vaccines” at the stage of clinical trials in humans. Hopes are high ...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
Over 40 million people recover from coronavirus
More than two-thirds of the over 58 million people infected by COVID-19 across the world have recovered from the disease after treatment. The post Over 40 million people recover from coronavirus appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.
- 1
- 2
